Related Experiment Video
Updated: Feb 10, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Emerging therapies for hemophilia: controversies and unanswered questions
Valder R Arruda1,2,3, Bhavya S Doshi1, Benjamin J Samelson-Jones1,2
1The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Abstract:
Several new therapies for hemophilia have emerged in recent years. These strategies range from extended half-life factor replacement products and non-factor options with improved pharmacokinetic profiles to gene therapy aiming for phenotypic cure. While these products have the potential to change hemophilia care dramatically, several challenges and questions remain regarding broader applicability, long-term safety, and which option to pursue for each patient. Here, we review these emerging therapies with a focus on controversies and unanswered questions in each category.
More Related Videos
Related Concept Videos
Emerging Adulthood
Introduction Cardiac Emergencies
Gene Therapy
Applications of GIS: Disaster Management and Emergency Response
Group Therapy
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...

